Validation of L19-conjugated gold nanoparticles for V targeting: a novel approach to image progressive atherosclerotic lesions in a transgenic mouse mode

17 April 2026 (16:10 - 17:10)
Organised by: Logo
Congress Presentation Part of: Extracellular vesicles and nanoparticles in vascular disease Biomarkers Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science